These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28714210)

  • 1. NAM 2017 report: A national plan to eliminate hepatitis B and C in the United States by 2030 and the AASLD's response.
    Rosen HR; Ghany MG; Chung RT; Lok ASF
    Hepatology; 2017 Oct; 66(4):1020-1022. PubMed ID: 28714210
    [No Abstract]   [Full Text] [Related]  

  • 2. Meeting of the International Task Force for Disease Eradication, June 2017.
    Wkly Epidemiol Rec; 2017 Sep; 92(37):537-56. PubMed ID: 28914042
    [No Abstract]   [Full Text] [Related]  

  • 3. Global Elimination of Chronic Hepatitis.
    Thomas DL
    N Engl J Med; 2019 May; 380(21):2041-2050. PubMed ID: 31116920
    [No Abstract]   [Full Text] [Related]  

  • 4. Control of hepatitis B and C worldwide.
    Aggarwal R; Goel A
    BMJ; 2009 Oct; 339():b4431. PubMed ID: 19864363
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatitis over hepatitis. Its time for prevention].
    Guardia J
    Med Clin (Barc); 2008 Oct; 131(14):536-7. PubMed ID: 19080827
    [No Abstract]   [Full Text] [Related]  

  • 6. A National Strategy for the Elimination of Viral Hepatitis Emphasizes Prevention, Screening, and Universal Treatment of Hepatitis C.
    Buckley GJ; Strom BL
    Ann Intern Med; 2017 Jun; 166(12):895-896. PubMed ID: 28384754
    [No Abstract]   [Full Text] [Related]  

  • 7. The Institute of Medicine report on viral hepatitis: a call to action.
    Sanyal AJ;
    Hepatology; 2010 Mar; 51(3):727-8. PubMed ID: 20198626
    [No Abstract]   [Full Text] [Related]  

  • 8. Breaking the silence on viral hepatitis.
    Valdiserri RO; Koh HK
    Ann Intern Med; 2014 Jul; 161(2):147-8. PubMed ID: 24781348
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chronic viral hepatitis B and C. Epidemiology, diagnosis, etiology, prevention].
    Castera L; Dhumeaux D; Pawlotsky JM
    Rev Prat; 2001 Jun; 51(11):1247-57. PubMed ID: 11503496
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fighting against viral hepatitis B and C: which policy for prevention?].
    Jullien-Depradeux AM; Le Quellec-Nathan M; Postel-Vinay N; Coquin Y; Dab W
    Rev Prat; 2005 Mar; 55(6):585-6. PubMed ID: 15913108
    [No Abstract]   [Full Text] [Related]  

  • 11. Reports from today's health care environment on the implementation of screening, diagnosis, and treatment recommendations.
    Kim WR; Valdiserri RO; Wright LN; Manos MM; Do ST
    J Fam Pract; 2010 Apr; 59(4 Suppl):S43-50. PubMed ID: 20398590
    [No Abstract]   [Full Text] [Related]  

  • 12. Transforming the current infrastructure for combating HBV and HCV infections.
    Kim WR; Ward JW; Cheever LW; Dan C; Dee L; Zola J
    J Fam Pract; 2010 Apr; 59(4 Suppl):S65-70. PubMed ID: 20398593
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving communication about viral hepatitis in Africa.
    Shimakawa Y; Pourette D; Bainilago L; Enel C; Sombié R; Rado R; Lemoine M; Giles-Vernick T
    Lancet Infect Dis; 2017 Jul; 17(7):688-689. PubMed ID: 28653627
    [No Abstract]   [Full Text] [Related]  

  • 14. [Viral hepatitis. Prevention, screening and research].
    de la Brière A
    Soins; 2013 Nov; (780):19. PubMed ID: 24409608
    [No Abstract]   [Full Text] [Related]  

  • 15. Transforming strategies for the prevention of chronic HBV and HCV infections.
    Ward JW; Hu DJ; Alter MJ; Kanwal F; Taylor C; Block JM; Caballero JB; Chase D; Saly M; Sandt L; Swan T
    J Fam Pract; 2010 Apr; 59(4 Suppl):S23-8. PubMed ID: 20398587
    [No Abstract]   [Full Text] [Related]  

  • 16. Consensus statements on the prevention and management of hepatitis B and hepatitis C in the Asia-Pacific region. Core Working Party for Asia-Pacific Consensus on Hepatitis B and C.
    J Gastroenterol Hepatol; 2000 Aug; 15(8):825-41. PubMed ID: 11022822
    [No Abstract]   [Full Text] [Related]  

  • 17. Transforming strategies to provide access to care.
    Jacobson IM; Wang S; Edlin BR; Smith VK; Chow EA
    J Fam Pract; 2010 Apr; 59(4 Suppl):S59-64. PubMed ID: 20398592
    [No Abstract]   [Full Text] [Related]  

  • 18. Global elimination of hepatitis C virus by 2030: why not?
    Dore GJ; Martinello M; Alavi M; Grebely J
    Nat Med; 2020 Feb; 26(2):157-160. PubMed ID: 32047317
    [No Abstract]   [Full Text] [Related]  

  • 19. [Incidence of infectious hepatitis in the Russian Federation and sociomedical measures to prevent its prevalence].
    Onishchenko GG
    Vestn Ross Akad Med Nauk; 2001; (8):31-4. PubMed ID: 11552622
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of hepatitis virus infections.
    Alter HJ
    Haemophilia; 2008 Jul; 14 Suppl 3():26-32. PubMed ID: 18510518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.